510(k) Report

510(k) · Cleared

Recalled · Class II · 2009

Harmonie System

K083577510(k) AbbreviatedCleared Aug 29, 2011999-day reviewClass II21 CFR 882.1400Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Stellate Systems · GWQ Full-Montage Standard Electroencephalograph

Cleared on Aug 29, 2011 as substantially equivalent to K010728 (Stellate Systems, 2001) and 1 other predicate after a 999-day review. Its family tree reaches back 3 generations to 2001. It has been recalled once.

Decided
Aug 29, 2011
Review
999 days
Class
Class II
Product code
GWQ
Recalls
1
Predicates
2

Its longest line of descent runs back 3 generations to K003154 (2001). 4 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestorK003154 · Mizar, Basis BE, Sandman Digital · Eb Neuro S.P.A. · 2001K041198 · NIC36 Amplifier · Eb Neuro S.P.A. · 2004K053606 · BE Plus / Aura-LTM64 Amplifier · Eb Neuro S.P.A. · 20062000200220042006200820102012
  1. Root · 3 generations backK003154 Mizar, Basis BE, Sandman DigitalEb Neuro S.P.A. · 2001
  2. 2 generations backK041198 NIC36 AmplifierEb Neuro S.P.A. · 2004
  3. 1 generation backK053606 BE Plus / Aura-LTM64 AmplifierEb Neuro S.P.A. · 2006
  4. This deviceK083577 Harmonie SystemStellate Systems · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K003154Mizar, Basis BE, Sandman DigitalEb Neuro S.P.A.2001—
−2K041198NIC36 AmplifierEb Neuro S.P.A.2004—
−1K053606BE Plus / Aura-LTM64 AmplifierEb Neuro S.P.A.2006—
0 (this device)K083577Harmonie SystemStellate Systems2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K083577, 2001–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWQ device

  1. #1 K260455 New Wave Systemscore 13.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K010728Harmone-Schwarzer Eeg SystemStellate Systems20011
*K053606BE Plus / Aura-LTM64 Amplifier
Summary page 1
…sification name - EEG/PSG Monitoring (21 CFR 882.1400 Product Code GWQ) The Harmonie System is substantially equivalent to K(01 0728 - Harmonie Schwarzer EEG System and K053606 - BE Plus / AURA-LTM64 Amplifier. Device Description: The Harmonie System is a data acquisition device that can record up to 128…
Eb Neuro S.P.A.2006—

Also cleared against K010728: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 6, 2009Class IIZ-1080-2013No Marketing ApplicationThe firm is initiating this recall because the implied or stated indications in their labeling associated with Harmonie software have not yet been cleared by the FDA for sale in the USA.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 3.4 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • 1 other device also cites its predicate K010728.

How does its category compare?

All GWQ devices

GWQ Full-Montage Standard Electroencephalograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · GWQ

1in 2024

2007: 12008: 22010: 32011: 42012: 42013: 22014: 22015: 32016: 32017: 52018: 82020: 62022: 32023: 62024: 12026 (partial year): 2
2007high 8 (2018) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWQ

137in 2023

2010: 73 days median2011: 220 days median2012: 208 days median2015: 276 days median2016: 50 days median2017: 181 days median2018: 150 days median2020: 216 days median2022: 216 days median2023: 137 days median
2007high 276 (2015) · low 50 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWQ

1in 2020

2007: 52008: 22009: 12010: 12015: 22019: 22020: 12026 (partial year): 1
2007high 5 (2007) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWQ

13in 2025

2007: 112008: 82009: 72010: 122011: 62012: 92013: 42014: 72015: 132016: 282017: 172018: 152019: 162020: 302021: 202022: 162023: 202024: 172025: 13
2007high 30 (2020) · low 4 (2013)2025

MAUDE reports naming product code GWQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—511
20082—28
20090—17
2010373112
2011422006
2012420809
20132—04
20142—07
20153276213
2016350028
20175181017
20188150015
20190—216
20206216130
20210—020
20223216016
20236137020
20241—017
20250—013
20262—1—

What is it indicated for?

The Harmonie System is indicated for the acquisition, display, review, analysis and archiving of physiological signals including patient video obtained during routine EEG examinations, Long-Term Monitoring in Epilepsy (LTM) and Sleep Studies (polysomnography or PSG) in patients of all ages. The seizure detection component of the software is intended for post-hoc review for marking sections of the EEG that may correspond to electrographic seizures in…

Read the full statement (178 words)

The Harmonie System is indicated for the acquisition, display, review, analysis and archiving of physiological signals including patient video obtained during routine EEG examinations, Long-Term Monitoring in Epilepsy (LTM) and Sleep Studies (polysomnography or PSG) in patients of all ages.

The seizure detection component of the software is intended for post-hoc review for marking sections of the EEG that may correspond to electrographic seizures in adults only. The Burst-Suppression component is intended to be used for the quantification and recognition (mark) of sections of the EEG and PSG that may contain patterns of interest. The seizure detection component and Burst-Suppression Module are for use in adults only.

The Harmonie software is not intended to replace conventional devices or methods used for sleep monitoring in critical care or intra-operative settings.

In no way are any of the system functions represented as being in and of themselves diagnostic. The system requires competent user input, and its Output must be reviewed and interpreted by a physician or other trained health care professional who will exercise professional judgment in using this information.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K083577: Harmonie System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K083577

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026